Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2565 (LINC02565)

Target
LINC02565
Molecular classification
Long non-coding RNA (lncRNA), Intergenic non-protein coding RNA, Other (non-coding transcript)
01

Overview

Long intergenic non-protein coding RNA 2565 (LINC02565) is a non-coding RNA gene that does not encode a protein. It belongs to the long non-coding RNA (lncRNA) subclass, defined as RNA molecules longer than 200 nucleotides that do not overlap coding genes and typically lack protein-coding capacity[1][5][3]. LINC02565’s sequence is autonomously transcribed from intergenic regions of the genome. While many lncRNAs are known to remodel chromatin, regulate gene expression, and contribute to various biological processes and diseases, there is currently no direct evidence specifying the function, disease involvement, or therapeutic targeting of LINC02565. It is listed in major gene databases (GeneCards, BioGPS, Ensembl, NCBI) as a lncRNA, but no additional annotation for molecular activity, disease association, or druggability is available as of this writing[1][5][3].

Other names
LINC02565Long intergenic non-protein coding RNA 2565
02

Biological functions

Unknown (no specific function attributed; generally lncRNAs can regulate gene expression, chromatin structure, transcription, or RNA stability)Other (potential regulatory roles typical of lncRNAs)
03

Disease associations

Unknown (no known association with cancer, inflammation, or other diseases)Other (lncRNAs are broadly implicated in various diseases, but no data ties LINC02565 to any particular condition)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2565 (LINC02565).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2565 (LINC02565).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call